Literature DB >> 33814841

Efficacy of Periareolar Versus Peritumoral Injection of TC99-Labelled Sulphur Colloid and Methylene Blue Dye for Detection of Sentinel Lymph Node in Patients with Early Breast Cancer: a Comparative Study.

Chanchal Malhotra1, Richa Pawar2, Sanjeev Patni1, Mitesh Kaushik1, Nivedita Sharma1.   

Abstract

Sentinel lymph node biopsy using dual methods of blue dye and radioactive isotope is what is practised as the standard of care at most of the centres. The combined use of radioactive colloid and blue dye injection is considered the gold standard for axillary sentinel lymph node biopsy in breast cancer with a 97% accuracy rate. The aim of this study is to determine the optimal injection site for methylene blue dye and Tc99-labelled sulphur colloid for sentinel lymph node biopsy in early breast cancer. In both periareolar and peritumoral groups of patients, overall rate of identifying sentinel lymph node (hot, blue and hot and blue nodes) with dual dye was comparable (100% and 96.36%) with p value = 0.475. Also in both groups of patients, overall rate of getting pathological positive sentinel lymph node on final histopathological report was comparable (52.73% and 45.28%) with p value = 0.561. Periareolar versus peritumoral injection of dual dye shows comparable success rates for axillary sentinel lymph node identification and can be considered rapid and reliable method. However, the periareolar route is technically simple and especially privileged in nonpalpable (T0) and upper outer quadrant lesions mainly for the prevention of the shine through phenomenon. © Indian Association of Surgical Oncology 2020.

Entities:  

Keywords:  Axillary lymph node dissection; Methylene blue dye; Sentinel lymph node biopsy; TC99-labelled sulphur colloid

Year:  2020        PMID: 33814841      PMCID: PMC7960868          DOI: 10.1007/s13193-020-01235-y

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  11 in total

Review 1.  Rationale for superficial injection techniques in lymphatic mapping in breast cancer patients.

Authors:  Omgo E Nieweg; Susanne H Estourgie; Maartje C van Rijk; Bin B R Kroon
Journal:  J Surg Oncol       Date:  2004-09-15       Impact factor: 3.454

2.  Low axillary sampling in clinically node-negative operable breast cancer.

Authors:  V Parmar; R Hawaldar; M S Nadkarni; R A Badwe
Journal:  Natl Med J India       Date:  2009 Sep-Oct       Impact factor: 0.537

3.  Sentinel Lymph Node Biopsy in Patients with Breast Cancer: Comparison of Peritumoral and Periareolar Injection.

Authors:  T Rosenow; C Biedendieck; H Fricke; M Brinkmann; U Cirkel; W-D Reinbold; E Fricke
Journal:  Geburtshilfe Frauenheilkd       Date:  2012-11       Impact factor: 2.915

4.  A second radioisotope injection enhances intraoperative sentinel node identification in breast cancer patients without visualized nodes on preoperative lymphoscintigraphy.

Authors:  J P Leikola; E A Leppänen; K A J von Smitten; M H K Leidenius
Journal:  Acta Radiol       Date:  2006-10       Impact factor: 1.990

5.  Comparison between periareolar and peritumoral injection of radiotracer for sentinel lymph node biopsy in patients with breast cancer.

Authors:  Kenzo Shimazu; Yasuhiro Tamaki; Tetsuya Taguchi; Yuuki Takamura; Shinzaburo Noguchi
Journal:  Surgery       Date:  2002-03       Impact factor: 3.982

6.  The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures.

Authors:  Arpana M Naik; Jane Fey; Mary Gemignani; Alexandra Heerdt; Leslie Montgomery; Jeanne Petrek; Elisa Port; Virgilio Sacchini; Lisa Sclafani; Kimberly VanZee; Raquel Wagman; Patrick I Borgen; Hiram S Cody
Journal:  Ann Surg       Date:  2004-09       Impact factor: 12.969

7.  Combination blue dye sentinel lymph node biopsy and axillary node sampling: the Edinburgh experience.

Authors:  U Chetty; P K Y Chin; P H S Soon; W Jack; J St J Thomas
Journal:  Eur J Surg Oncol       Date:  2007-05-11       Impact factor: 4.424

Review 8.  Alternative sites of injection for sentinel lymph node biopsy in breast cancer.

Authors:  Liesl Celliers; G Bruce Mann
Journal:  ANZ J Surg       Date:  2003-08       Impact factor: 1.872

9.  Lymphoscintigraphy with peritumoral injection versus lymphoscintigraphy with subdermal periareolar injection of technetium-labeled human albumin to identify sentinel lymph nodes in breast cancer patients.

Authors:  Giuseppe Caruso; Calogero Cipolla; Renato Costa; Alessandra Morabito; Stefania Latteri; Salvatore Fricano; Sergio Salerno; Mario Adelfio Latteri
Journal:  Acta Radiol       Date:  2013-08-07       Impact factor: 1.990

10.  Current management of the axilla in patients with clinically node-negative breast cancer: a nationwide survey of United Kingdom breast surgeons.

Authors:  Lucy Mansfield; Isi Sosa; Roberta Dionello; Ash Subramanian; Haresh Devalia; Kefah Mokbel
Journal:  Int Semin Surg Oncol       Date:  2007-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.